Orchestra BioMed Holdings (OBIO) Other Gross PP&E Adjustments (2022 - 2025)
Orchestra BioMed Holdings (OBIO) has disclosed Other Gross PP&E Adjustments for 4 consecutive years, with $1.5 million as the latest value for Q3 2025.
- On a quarterly basis, Other Gross PP&E Adjustments rose 96.31% to $1.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $1.5 million, a 96.31% increase, with the full-year FY2024 number at $584000.0, down 23.96% from a year prior.
- Other Gross PP&E Adjustments was $1.5 million for Q3 2025 at Orchestra BioMed Holdings, up from $1.0 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $1.5 million in Q3 2025 to a low of -$1.5 million in Q1 2023.
- A 4-year average of $560333.3 and a median of $763500.0 in 2023 define the central range for Other Gross PP&E Adjustments.
- Peak YoY movement for Other Gross PP&E Adjustments: skyrocketed 370.42% in 2023, then decreased 23.96% in 2024.
- Orchestra BioMed Holdings' Other Gross PP&E Adjustments stood at -$284000.0 in 2022, then surged by 370.42% to $768000.0 in 2023, then fell by 23.96% to $584000.0 in 2024, then surged by 155.14% to $1.5 million in 2025.
- Per Business Quant, the three most recent readings for OBIO's Other Gross PP&E Adjustments are $1.5 million (Q3 2025), $1.0 million (Q2 2025), and $843000.0 (Q1 2025).